Systemic lupus erythematosus |
21 |
0.094595 |
2.77E−10 |
HIST1H4F, HIST1H4E, HIST1H2BI, HIST2H3D, HIST2H2AB, HIST1H2AH, HIST1H2BO, HIST1H4J, HIST1H4L, C1S, HIST1H4K, HIST1H4A, HIST2H2AC, HIST1H2AB, C1R, HIST1H3I, 105369230, HIST1H3H, HIST1H2AM, HIST1H3A, HIST1H2BN |
Alcoholism |
20 |
0.096154 |
5.59E−10 |
BDNF, HIST1H4F, HIST1H4E, HIST1H2BI, HIST2H3D, HIST2H2AB, HIST1H2AH, HIST1H2BO, HIST1H4J, HIST1H4L, HIST1H4K, SHC2, HIST1H4A, HIST2H2AC, HIST1H2AB, HIST1H3I, HIST1H3H, HIST1H2AM, HIST1H3A, HIST1H2BN |
Malaria |
7 |
0.102941 |
1.67E−04 |
CXCL8, THBS2, THBS1, GYPC, THBS3, COMP, SDC1 |
Complement and coagulation cascades |
9 |
0.076271 |
2.07E−04 |
CLU, TFPI, SERPINE1, C1S, C1R, CD55, CFI, SERPINB2, CFB |
ECM-receptor interaction |
8 |
0.063492 |
0.001548 |
ITGA10, TNC, THBS2, THBS1, THBS3, COMP, SDC1, COL4A1 |
Wnt signaling pathway |
10 |
0.052632 |
0.001745 |
GREM1, PLCB4, CCND1, FZD8, DKK1, DVL2, PORCN, SERPINF1, CCND2, SFRP4 |
AGE-RAGE signaling pathway in diabetic complications |
8 |
0.061069 |
0.00198 |
STAT5A, PLCB4, CXCL8, CCND1, SERPINE1, EDN1, STAT1, COL4A1 |
Pathways in cancer |
24 |
0.032742 |
0.002047 |
NOTCH3, DAPK2, STAT5A, SULF2, PLCB4, CXCL8, JUP, FGF2, MMP9, FGF5, CCND1, GLI3, JAG1, FZD8, GSTM4, STAT1, CXCL12, DVL2, SLC2A1, TXNRD1, ABI3BP, IGF2, COL4A1, CCND2 |
Protein digestion and absorption |
7 |
0.066667 |
0.002287 |
COL16A1, SLC1A1, COL5A3, SLC7A8, COL14A1, VWCE, COL4A1 |
Bladder cancer |
5 |
0.089286 |
0.002755 |
DAPK2, CXCL8, MMP9, CCND1, THBS1 |